Rapport d’analyse de la taille, de la part et des tendances du marché mondial des services de fertilité – Aperçu du secteur et prévisions jusqu’en 2031

Analyse du marché des services de fertilité  

Le marché des services de fertilité connaît une croissance robuste, portée par une combinaison de taux d’infertilité croissants, de progrès dans les technologies de procréation assistée (ART) et de sensibilisation croissante à la santé reproductive. Parmi les développements notables dans ce secteur, citons l’intégration de technologies de pointe, telles que les tests génétiques préimplantatoires (PGT), qui permettent de dépister les troubles génétiques des embryons, améliorant ainsi les taux de réussite de la fécondation in vitro (FIV). En outre, le marché a connu une augmentation des services de télémédecine, permettant aux patients d’accéder à des consultations et des traitements de fertilité dans le confort de leur domicile. L’acceptation croissante des méthodes de préservation de la fertilité, en particulier chez les jeunes femmes qui souhaitent retarder l’accouchement, façonne également le paysage du marché. De plus, les collaborations entre les cliniques de fertilité et les entreprises de biotechnologie favorisent l’innovation dans les traitements de fertilité, conduisant à des solutions personnalisées adaptées aux besoins individuels. Grâce à ces développements, le marché des services de fertilité est prêt à poursuivre sa croissance, à répondre aux demandes évolutives des patients et à améliorer l’écosystème global de la santé reproductive.

Taille du marché des services de fertilité

Français La taille du marché mondial des services de fertilité a été évaluée à 20,24 milliards USD en 2023 et devrait atteindre 36,63 milliards USD d'ici 2031, avec un TCAC de 7,70 % au cours de la période de prévision de 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Tendances du marché des services de fertilité

« Demande croissante de préservation de la fertilité »

Le marché des services de fertilité connaît une croissance significative en raison de l’augmentation des taux d’infertilité et d’une sensibilisation croissante à la santé reproductive. En particulier, les technologies de procréation assistée (PMA) telles que la fécondation in vitro (FIV) ont gagné en popularité en tant que solutions efficaces pour les couples qui ont du mal à concevoir. Une tendance notable sur le marché est la demande croissante de préservation de la fertilité, en particulier chez les femmes qui retardent l’accouchement pour des raisons professionnelles ou personnelles. Par exemple, de nombreuses cliniques proposent désormais des services de congélation d’ovules pour aider les femmes à conserver leurs options de procréation. En outre, les progrès des technologies de tests génétiques et de sélection d’embryons améliorent les taux de réussite, ce qui rend la PMA plus attrayante. En conséquence, le marché des services de fertilité devrait encore se développer, avec des investissements accrus dans des solutions innovantes qui répondent aux divers besoins des patients. Cette croissance reflète un changement sociétal plus large vers la priorité accordée à la santé reproductive et la fourniture aux individus des outils et du soutien dont ils ont besoin pour fonder une famille.

Portée du rapport et segmentation du marché des services de fertilité    

Fertility Services Market Definition

Fertility services refer to a comprehensive range of medical treatments and interventions designed to assist individuals and couples in achieving pregnancy. These services include diagnostic testing to identify fertility issues, assisted reproductive technologies (ART) such as in vitro fertilization (IVF) services and intrauterine insemination (IUI), as well as fertility preservation techniques such as egg or sperm freezing. In addition, fertility services often provide counseling and support to help individuals navigate the emotional challenges associated with infertility, ultimately aiming to enhance reproductive health and facilitate family planning.

Fertility Services Market Dynamics

Drivers

• Rising Infertility Rates

Rising infertility rates among couples are a significant driver of demand for fertility services, influenced by factors such as delayed marriage, lifestyle choices, and environmental factors. According to the World Health Organization (WHO), approximately 15% of couples globally experience infertility, with the prevalence rising due to changing societal norms, where individuals often prioritize education and career before starting families. In addition, lifestyle factors, such as unhealthy diets, increased stress levels, and rising obesity rates, further contribute to fertility challenges. For instance, the American Society for Reproductive Medicine (ASRM) reports that conditions such as polycystic ovary syndrome (PCOS) and male infertility are becoming more common, exacerbating the need for assisted reproductive technologies. As couples face these challenges, the demand for fertility services continues to grow, driving innovations and expansions in the market.

• Growing Market for Egg Freezing

The growing market for egg freezing is a significant driver in the fertility services sector, reflecting changing societal norms and increasing awareness among women about their reproductive options. According to the American Society for Reproductive Medicine (ASRM), egg freezing cycles increased to 29,803, up from 24,560 in 2021. Additionally, advancements in freezing technologies, such as vitrification, have significantly improved the success rates of thawing frozen eggs, further encouraging women to consider this option. As more fertility clinics offer egg freezing services and provide educational resources, this growing awareness is likely to drive demand, making egg freezing a key component of the fertility services market, thereby driving the market growth.

Opportunities

• Increasing Awareness Regarding In Vitro Fertilization (IVF)

The increase in awareness regarding in vitro fertilization (IVF) is creating significant opportunities within the global fertility services market. As more individuals and couples become informed about the benefits of IVF, particularly in addressing infertility challenges, the demand for these services has surged. Educational initiatives, social media campaigns, and success stories shared by patients are helping to demystify the IVF process and reduce stigma surrounding fertility treatments. For instance, organizations such as the American Society for Reproductive Medicine (ASRM) provide resources and information that empower couples to make informed decisions about their reproductive health. Additionally, the rise of fertility clinics offering comprehensive services, such as egg freezing and fertility preservation, caters to the evolving needs of patients, especially those delaying parenthood for personal or professional reasons. This heightened awareness and acceptance of IVF, combined with advancements in reproductive technologies, is expected to drive significant growth in the global fertility services market, creating new opportunities for service providers and innovators in the field.

• Increasing Advancements in Genetic Testing

Advancements in technology are revolutionizing the fertility services market, particularly through innovations in assisted reproductive technologies (ART) that enhance success rates and attract a growing patient base. For instance, Advancements in genetic testing, such as preimplantation genetic testing for aneuploidy (PGT-A), allow for the screening of embryos for chromosomal abnormalities before implantation, further increasing the likelihood of successful pregnancies. As these technologies become more widely adopted, fertility clinics that integrate them into their practice can significantly improve patient outcomes and satisfaction, thus positioning themselves competitively in a rapidly evolving market. This technological evolution fosters patient trust and opens new opportunities for clinics focused on providing cutting-edge fertility solutions.

Restraints/Challenges

• High Treatment Costs

High treatment costs present a substantial challenge in the fertility services market, as the expenses associated with procedures such as In-Vitro Fertilization (IVF) and other assisted reproductive technologies can be prohibitively high for many patients. The financial burden can lead to significant stress for couples trying to conceive, especially since multiple treatment cycles are often needed for success. Furthermore, many insurance plans do not cover fertility treatments, limiting access for a considerable portion of the population. This lack of coverage disproportionately affects low- and middle-income individuals, who may be forced to make difficult decisions regarding their reproductive health. As a result, high treatment costs hinder access to essential medical care and contribute to growing disparities in reproductive health outcomes.

• Ethical Concerns Surrounding Assisted Reproductive Technologies

Ethical concerns surrounding assisted reproductive technologies (ART) represent a significant challenge in the fertility services market, as they encompass various implications related to genetic testing, embryo selection, and the use of donor gametes. For instance, the practice of embryo selection, which involves choosing embryos with the highest likelihood of successful implantation based on genetic profiling, raises questions about "designer babies" and the moral implications of selecting traits. These ethical dilemmas can create hesitancy among potential patients, as individuals may grapple with the moral considerations of their choices regarding reproduction. In addition, public backlash can arise against certain practices, leading to increased scrutiny and potential regulatory restrictions on ART. Such ethical complexities can deter individuals from seeking fertility treatments, ultimately impacting market growth and the willingness of healthcare providers to offer certain services, thereby presenting a notable challenge within the fertility services sector.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Fertility Services Market Scope

The market is segmented on the basis of infertility, procedure, services, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Diagnosis
• Male infertility
  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Microscopic Examination
  • Sperm Agglutination
  • Computer Assisted Semen Analysis
  • Sperm Penetration Assay
  • Others
• Female infertility
  • Ovarian reserve testing
  • Hysterosalpingography
  • Hormone testing
  • Other Tests
• Treatment
  • In-Vitro Fertilization (IVF)
  • Artificial Insemination
• Preservation
  • Egg & Embryo Freezing
  • Sperm Banking

Procedure

• Assisted Reproductive Technology (ART)
• In-Vitro Fertilization (IVF)
• Artificial Insemination
• Surrogacy
• Others

Services

• Donor services
• Non-donor services

End-User

• Fertility clinics
• Hospitals
• Clinical research institutes
• Surgical centers

Fertility Services Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, infertility, procedure, services, and end-user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the fertility services market, driven by several key factors, including declining fertility rates and a rising median age of motherhood. As more women delay childbirth for various reasons, the demand for fertility services has increased significantly. In addition, the growing prevalence of obesity in the region further contributes to fertility challenges, prompting individuals and couples to seek assisted reproductive technologies and related services to enhance their chances of conception.

Asia-Pacific region is projected to experience the highest growth rate from 2022 to 2029, driven primarily by a notable decline in fertility rates. This trend not only impacts demographic dynamics but also influences healthcare demand and resource allocation. As a result, the region's healthcare sector is expected to adapt to changing population needs and preferences, fostering innovation and investment opportunities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Fertility Services Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Fertility Services Market Leaders Operating in the Market Are:

• Olympus Corporation (Japan)
• The Cooper Companies Inc. (U.S.)
• Instituto Bernabeu (Spain)
• VirtusHealth (Australia)
• CooperSurgical, Inc. (U.S.)
• Vitrolife (Sweden)
• Care Fertility (U.K.)
• INVO Bioscience (U.S.)
• Monash IVF (Australia)
• Fertility Focus Limited (U.S.)
• Carolinas Fertility Institute (U.S.)
• Apollo Hospitals Enterprise Ltd. (India)
• Merck KGaA (Germany)
• LABOTECT GMBH (Germany)
• Medicover AB (Sweden)

Latest Developments in Fertility Services Market

• In June 2023, Quantum Health formed a partnership with Progyny, Inc. to launch Quantum Health's Comprehensive Care Solutions platform, specifically designed to provide family building and fertility solutions. This collaboration aims to enhance access to fertility services, offering a streamlined approach to care that supports individuals and couples on their journey to parenthood
• In April 2023, Cryoport, Inc. entered into a three-year supply chain agreement with Boston IVF to facilitate the shipment of reproductive materials across the United States. This partnership is intended to ensure the safe and timely transport of critical biological samples, such as eggs, sperm, and embryos, which are essential for fertility treatments
• In October 2022, Maven Clinic, a U.S.-based company specializing in telemedicine and virtual clinic services for women’s and family health, partnered with Indira IVF, an India-based infertility specialty clinic chain. This collaboration aims to extend access to Indira IVF's high-quality clinical care to Maven's members in India, enhancing the support available for family-building needs
• En juillet 2021, Hamilton Throne Ltd., un fournisseur mondial de recherche sur la procréation médicalement assistée (PMA), a acquis IVFTECH ApS (IVFtech) et sa société affiliée, K4 Technology ApS. Cette acquisition renforce l'engagement d'IVFtech à fournir des postes de travail à flux laminaire et des incubateurs de grande capacité pour la technologie de procréation médicalement assistée (PMA), en s'appuyant sur les ressources et l'expertise de K4 Technology. Ensemble, ils visent à améliorer la qualité et l'efficacité des solutions PMA dans l'industrie
• En mai 2021, Virtus Health, leader mondial des services de procréation assistée (SRA), a annoncé un partenariat stratégique avec Drop Bio, une société australienne de biotechnologie et de santé numérique spécialisée dans l'inflammation chronique. Cette collaboration vise à optimiser les avancées en matière de fertilité de précision, en tirant parti de l'expertise des deux entreprises pour améliorer les résultats de fertilité et adapter les traitements aux besoins individuels des patients
• En juin 2020, Ferring BV et Igenomix ont conclu une collaboration de recherche de quatre ans axée sur le développement de produits thérapeutiques innovants pour le traitement des pathologies liées à la grossesse. Ce partenariat associe l'expertise de Ferring en médecine de la reproduction aux capacités d'analyse génétique de pointe d'Igenomix

SKU-29201